Roche Applied Science
 |
This article appears to be written like an advertisement. Please help improve it by rewriting promotional content from a neutral point of view and removing any inappropriate external links. (November 2011) |
 |
|
| Type | Public (NYSE: PKI) |
|---|---|
| Industry | Health Sciences, Pharmacology, Biotechnology |
| Headquarters | Penzberg, Upper Bavaria, Germany |
| Products | Analytical instruments, Genetic Screening tools, Life & Analytical Science software and instruments |
| Website | www.www.roche-applied-science.com |
Roche Applied Science is producers of reagents and systems for life science research, with focus on DNA sequencing, microarrays, gene expression, and cell analysis. Important applications fields of the company´s products are Biotech R&D and Pharma R&D. The company´s ´s product portfolio includes the Genome Sequencer FLX Titanium, the LightCyler systems for real-time PCR, the NimbleGen microarrays for studying genomic variations, and the xCELLigence Systems for real-time, impedance-based, and label-free cellular analysis and in cell invasion/ migration studies. The company also offers reagents and systems for the pharmaceuticals and diagnostics industries.
Contents |
[edit] Locations
The company's headquarters is in Penzberg in Upper Bavaria, Germany; other main sites are Mannheim, Germany, Rotkreuz in Switzerland, Madison WI and Branford CT in the United States.
[edit] History
Roche Applied Science was founded in 1859 as Boehringer Mannheim, a developer of rare chemicals and pharmaceuticals. In the fifties, the bioreagents product line was developed according to the company’s own needs in diagnostics research. They were the first commercially important producer of restriction enzymes, they were the first supplier of Klenow enzyme for Sanger sequencing, and they are the only supplier of a system for the non-radioactive labeling of nucleic acid.
